CytomX Therapeutics Cash from Other Financing Activities (Quarterly) Analysis

CytomX Therapeutics, Inc. (CTMX)

5.54 -0.04 (-0.72%) USD | NASDAQ | Feb 24, 15:26

View Cash from Other Financing Activities (Quarterly) for CTMX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Other Financing Activities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Other Financing Activities (Quarterly) Benchmarks

Start Trial

REGENXBIO, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	Upgrade